162 related articles for article (PubMed ID: 6962686)
1. d-Amphetamine-induced anorexia and motor behavior after chronic treatment in rats: relationship with changes in the number of catecholamine receptor sites in the brain.
Bendotti C; Borsini F; Cotecchia S; De Blasi A; Mennini T; Samanin R
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):36-49. PubMed ID: 6962686
[TBL] [Abstract][Full Text] [Related]
2. Dissociation of receptor sensitivity changes in rat perifornical hypothalamus: a role for dopaminergic receptors in amphetamine anorexic tolerance.
Bhakthavatsalam P; Kamatchi GL; Ghosh MN
J Pharmacol Exp Ther; 1987 Jan; 240(1):196-202. PubMed ID: 3468240
[TBL] [Abstract][Full Text] [Related]
3. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
[TBL] [Abstract][Full Text] [Related]
4. Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine.
Ritz MC; Kuhar MJ
J Pharmacol Exp Ther; 1989 Mar; 248(3):1010-7. PubMed ID: 2703961
[TBL] [Abstract][Full Text] [Related]
5. Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats.
Shankar RP; Karan RS; Handu SS; Bhargava VK
Indian J Physiol Pharmacol; 2000 Jul; 44(3):355-8. PubMed ID: 10941627
[TBL] [Abstract][Full Text] [Related]
6. In vivo electrochemical and behavioral evidence for specific neural substrates modulated differentially by enkephalin in rat stimulant stereotypy and locomotion.
Broderick PA; Gardner EL; van Praag HM
Biol Psychiatry; 1984 Jan; 19(1):45-54. PubMed ID: 6538442
[TBL] [Abstract][Full Text] [Related]
7. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
Robbins TW; Roberts DC; Koob GF
J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
[TBL] [Abstract][Full Text] [Related]
8. Amphetamine behavioral toxicity: rotational behavior after chronic intrastriatal infusion.
Dougherty GG; Ellinwood EH
Biol Psychiatry; 1981 May; 16(5):479-88. PubMed ID: 7196774
[TBL] [Abstract][Full Text] [Related]
9. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration.
Peris J; Boyson SJ; Cass WA; Curella P; Dwoskin LP; Larson G; Lin LH; Yasuda RP; Zahniser NR
J Pharmacol Exp Ther; 1990 Apr; 253(1):38-44. PubMed ID: 2329520
[TBL] [Abstract][Full Text] [Related]
10. Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies.
Nemeroff CB; Luttinger D; Hernandez DE; Mailman RB; Mason GA; Davis SD; Widerlöv E; Frye GD; Kilts CA; Beaumont K; Breese GR; Prange AJ
J Pharmacol Exp Ther; 1983 May; 225(2):337-45. PubMed ID: 6682440
[TBL] [Abstract][Full Text] [Related]
11. Effect of gestational and neonatal styrene exposure on dopamine receptors.
Zaidi NF; Agrawal AK; Srivastava SP; Seth PK
Neurobehav Toxicol Teratol; 1985; 7(1):23-8. PubMed ID: 4039799
[TBL] [Abstract][Full Text] [Related]
12. Modulation of dopamine receptor sensitivity by estrogen.
Gordon JH; Borison RL; Diamond BI
Biol Psychiatry; 1980 Jun; 15(3):389-96. PubMed ID: 7189674
[TBL] [Abstract][Full Text] [Related]
13. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
Arnt J; Hyttel J; Overø KF
Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
[TBL] [Abstract][Full Text] [Related]
14. Chronic lithium treatment and dopamine-mediated behavior.
Ebstein RP; Eliashar S; Belmaker RH; Ben-Uriah Y; Yehuda S
Biol Psychiatry; 1980 Jun; 15(3):459-67. PubMed ID: 7189675
[TBL] [Abstract][Full Text] [Related]
15. Effect of prior sensitization of stereotypy on the development of tolerance to amphetamine-induced hypophagia.
Wolgin DL; Kinney GG
J Pharmacol Exp Ther; 1992 Sep; 262(3):1232-41. PubMed ID: 1527726
[TBL] [Abstract][Full Text] [Related]
16. The influence of antiserotonergic agents on the action of dopaminergic drugs.
Mogilnicka E; Scheel-Krüger J; Klimek V; Golembiowska-Nikitin K
Pol J Pharmacol Pharm; 1977; 29(1):31-8. PubMed ID: 140371
[TBL] [Abstract][Full Text] [Related]
17. Changes in rat dopamine- and serotonin function in vivo after prolonged administration of the specific 5-HT uptake inhibitor, citalopram.
Arnt J; Overø KF; Hyttel J; Olsen R
Psychopharmacology (Berl); 1984; 84(4):457-65. PubMed ID: 6441945
[TBL] [Abstract][Full Text] [Related]
18. Amphetamine-induced stereotypy: reply to Rebec and Bashore.
Kokkinidis L; Anisman H
Psychol Bull; 1983 Mar; 93(2):368-72. PubMed ID: 6682558
[No Abstract] [Full Text] [Related]
19. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine.
Spyraki C; Fibiger HC
Eur J Pharmacol; 1981 Sep; 74(2-3):195-206. PubMed ID: 7198991
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of dopamine D-2, 5-HT2 receptors and beta-adrenoceptors in rat brain after prolonged treatment with a new potential antidepressant, Lu 19-005.
Nowak G; Arnt J; Hyttel J; Svendsen O
J Neural Transm; 1985; 64(3-4):227-38. PubMed ID: 2418155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
